Ovarian Cancer Clinical Trial
Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function
Summary
The purpose of this study is to retrieve and cryopreserve ovarian tissue from females undergoing a treatment that may lead to irreversible loss of ovarian function.
Full Description
The aim of this preliminary study is to retrieve and properly cryopreserve ovarian tissue for autotransplantation in any premenopausal female whose ovarian function is threatened in a physiological, pathological or iatrogenic manner in an effort to observe the return of ovarian endocrine function and development of egg(s) appropriate for use in in vitro fertilization.
Eligibility Criteria
Inclusion Criteria:
Patient must be female.
Patient must have a disease process where the disease or its treatment adversely affects ovarian function.
Patient must be recommended for this study by their oncologist or specialist.
Patient (or legally authorized representative) must sign an informed consent.
Exclusion Criteria:
Patients cannot be male.
Patients must not be HIV positive.
Patient cannot have a poor diagnosis such that she is not expected to survive to adulthood.
Patient cannot have any medical condition that would contraindicate surgery.
Patient cannot have any medical condition that would contraindicate general anesthesia.
Patient cannot have any medical condition that would contraindicate pregnancy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Milwaukee Wisconsin, 53226, United States
Milwaukee Wisconsin, 53226, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.